Research & Development
28 September 2026 - Pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) reported on Monday that it has received tentative US Food and Drug Administra...
28 September 2026 - Netherlands-based holding company QIAGEN N.V. (NYSE:QGEN) (Frankfurt Prime Standard:QIA) announced on Monday that it has received US Food and Drug Administration (FDA) clearance fo...
28 September 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Sunday an expansion of the global Phase 3 MarsLight-11 trial, which is evaluating IBI363 (Takeda ...
25 September 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Fo...
25 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Friday that the US Food and Drug Administration (FDA) has accepted and granted Priority Review...
25 September 2026 - XtalPi (HKEX:2228), an AI- and robotics-driven drug and materials discovery company, announced on Thursday the submission of an Investigational New Drug (IND) application to the US...